Evidence map›Paper›PMID 40685375›Full record

ArticleScientific reports2025

Ziziphus nummularia extract attenuates inflammatory markers in RAW 264.7 macrophages.

Rola Abdallah, Serene Badran, Adnan Badran, Joelle Edward Mesmar, Elias Baydoun

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Anti-Inflammatory Activity ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rola AbdallahDepartment of Biology, American University of Beirut, Beirut, 1107, Lebanon.
Serene BadranDepartment of Orthodontics, Pediatric and Community Dentistry, University of Sharjah, Sharjah, 27272, United Arab Emirates.
Adnan BadranDepartment of Nutrition, University of Petra, Amman, 11196, Jordan.
Joelle Edward MesmarDepartment of Biology, American University of Beirut, Beirut, 1107, Lebanon. jm104@aub.edu.lb.
Elias BaydounDepartment of Biology, American University of Beirut, Beirut, 1107, Lebanon. eliasbay@aub.edu.lb.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While inflammation is a vital immune response to harmful stimuli, chronic inflammation has been associated with several diseases such as arthritis, cardiovascular disorders, and cancers. Plant extracts, rich in bioactive compounds, have been used in traditional medicine to manage inflammation by modulating inflammatory pathways. Specifically, Ziziphus nummularia (Sidr), known for its anti-inflammatory, antioxidant, and antimicrobial properties, contains flavonoids, saponins, triterpenoids, and phenolics, but its mechanisms of action remain unclear. This study investigated the anti-inflammatory effects of an ethanolic extract from Z. nummularia leaves (ZNE) in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. ZNE significantly reduced the expression of pro-inflammatory enzymes (COX2, iNOS), inhibited the production of inflammatory mediators (NO, ROS, TNF-α, IL-6), reduced cellular migration and modulated key signaling pathways (NF-κB, STAT-3, MAPKs). These findings highlight the potential of ZNE as a natural therapeutic agent for inflammation, warranting further exploration of its mechanism of action and potential clinical applications.

Indexed as

Anti-Inflammatory AgentsInflammationMacrophagesPlant ExtractsZiziphusAnimalsBiomarkersCell MovementCyclooxygenase 2Inflammation MediatorsLipopolysaccharidesMiceNF-kappa BNitric OxideNitric Oxide Synthase Type IIPlant LeavesAnti-Inflammatory AgentsBiomarkersCyclooxygenase 2Inflammation MediatorsLipopolysaccharidesNF-kappa BNitric OxideNitric Oxide Synthase Type IIPlant ExtractsReactive Oxygen SpeciesTumor Necrosis Factor-alphaAnti-inflammationMAPKsNK-κBRAW 264.7STAT-3Ziziphus nummularia

Identifiers

PMID40685375
PMCPMC12277454

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.